Jonathan B. Johnston

3.1k total citations · 1 hit paper
21 papers, 2.3k citations indexed

About

Jonathan B. Johnston is a scholar working on Molecular Biology, Epidemiology and Pharmacology. According to data from OpenAlex, Jonathan B. Johnston has authored 21 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Epidemiology and 6 papers in Pharmacology. Recurrent topics in Jonathan B. Johnston's work include Trypanosoma species research and implications (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Biochemical and Molecular Research (5 papers). Jonathan B. Johnston is often cited by papers focused on Trypanosoma species research and implications (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Biochemical and Molecular Research (5 papers). Jonathan B. Johnston collaborates with scholars based in United States, Brazil and Australia. Jonathan B. Johnston's co-authors include Paul R. Ortiz de Montellano, Alma L. Burlingame, Michael J. Trnka, Geeta J. Narlikar, Madeline M Keenen, David A. Agard, Sy Redding, Daniel Elnatan, Adam G. Larson and Hugues Ouellet and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Jonathan B. Johnston

21 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Liquid droplet formation by HP1α suggests a role for phase separation in heterochromatin

2017 1.2k citations Adam G. Larson, Daniel Elnatan et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan B. Johnston United States	19	1.8k	351	295	244	223	21	2.3k
Charles A. Lesburg United States	17	1.1k 0.6×	106 0.3×	336 1.1×	69 0.3×	352 1.6×	34	1.9k
Heini W. Dirr South Africa	31	3.1k 1.7×	357 1.0×	50 0.2×	138 0.6×	158 0.7×	112	3.5k
Andrew Binkowski United States	4	1.2k 0.7×	65 0.2×	126 0.4×	146 0.6×	174 0.8×	4	1.8k
John M. Ndungu United States	14	2.1k 1.1×	255 0.7×	87 0.3×	87 0.4×	41 0.2×	20	2.5k
Joseph Dundas United States	4	1.1k 0.6×	67 0.2×	72 0.2×	131 0.5×	131 0.6×	6	1.6k
Suparerk Borwornpinyo Thailand	20	587 0.3×	66 0.2×	115 0.4×	90 0.4×	118 0.5×	87	1.3k
Jean‐François Guichou France	23	967 0.5×	63 0.2×	124 0.4×	60 0.2×	83 0.4×	62	1.7k
Nidhi Singh India	19	702 0.4×	45 0.1×	106 0.4×	115 0.5×	113 0.5×	50	1.2k
Subramanyam Swaminathan United States	27	1.4k 0.7×	57 0.2×	62 0.2×	135 0.6×	147 0.7×	80	2.6k
Karunakaran Kalesh United Kingdom	18	697 0.4×	100 0.3×	103 0.3×	41 0.2×	61 0.3×	36	1.2k

Countries citing papers authored by Jonathan B. Johnston

Since Specialization

Citations

This map shows the geographic impact of Jonathan B. Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan B. Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan B. Johnston more than expected).

Fields of papers citing papers by Jonathan B. Johnston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan B. Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan B. Johnston. The network helps show where Jonathan B. Johnston may publish in the future.

Co-authorship network of co-authors of Jonathan B. Johnston

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan B. Johnston. A scholar is included among the top collaborators of Jonathan B. Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan B. Johnston. Jonathan B. Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, HyeongJun, Linda Yen, Somsakul Pop Wongpalee, et al.. (2019). The Gene-Silencing Protein MORC-1 Topologically Entraps DNA and Forms Multimeric Assemblies to Cause DNA Compaction. Molecular Cell. 75(4). 700–710.e6. 44 indexed citations

Larson, Adam G., Daniel Elnatan, Madeline M Keenen, et al.. (2017). Liquid droplet formation by HP1α suggests a role for phase separation in heterochromatin. Nature. 547(7662). 236–240. 1211 indexed citations breakdown →

Zhou, Coral Y., Caitlin I. Stoddard, Jonathan B. Johnston, et al.. (2017). Regulation of Rvb1/Rvb2 by a Domain within the INO80 Chromatin Remodeling Complex Implicates the Yeast Rvbs as Protein Assembly Chaperones. Cell Reports. 19(10). 2033–2044. 38 indexed citations

McCall, Laura‐Isobel, Jun Yong Choi, Débora Vieira, et al.. (2015). Targeting Ergosterol Biosynthesis in Leishmania donovani: Essentiality of Sterol 14alpha-demethylase. PLoS neglected tropical diseases. 9(3). e0003588–e0003588. 88 indexed citations

Vieira, Débora, Jun Yong Choi, Cláudia M. Calvet, et al.. (2014). Binding Mode and Potency of N-Indolyloxopyridinyl-4-aminopropanyl-Based Inhibitors Targeting Trypanosoma cruzi CYP51. Journal of Medicinal Chemistry. 57(23). 10162–10175. 17 indexed citations

Calvet, Cláudia M., Débora Vieira, Jun Yong Choi, et al.. (2014). 4-Aminopyridyl-Based CYP51 Inhibitors as Anti-Trypanosoma cruziDrug Leads with Improved Pharmacokinetic Profile and in Vivo Potency. Journal of Medicinal Chemistry. 57(16). 6989–7005. 38 indexed citations

Bryant, Clifford, Cláudia M. Calvet, Patricia S. Doyle, et al.. (2013). Chemical–biological characterization of a cruzain inhibitor reveals a second target and a mammalian off-target. Beilstein Journal of Organic Chemistry. 9. 15–25. 31 indexed citations

Gunatilleke, Shamila S., Cláudia M. Calvet, Jonathan B. Johnston, et al.. (2012). Diverse Inhibitor Chemotypes Targeting Trypanosoma cruzi CYP51. PLoS neglected tropical diseases. 6(7). e1736–e1736. 56 indexed citations

Johnston, Jonathan B., et al.. (2012). Substrate analog studies of the ω-regiospecificity of Mycobacterium tuberculosis cholesterol metabolizing cytochrome P450 enzymes CYP124A1, CYP125A1 and CYP142A1. Bioorganic & Medicinal Chemistry. 20(13). 4064–4081. 11 indexed citations

10.

Ouellet, Hugues, Jonathan B. Johnston, & Paul R. Ortiz de Montellano. (2011). Cholesterol catabolism as a therapeutic target in Mycobacterium tuberculosis. Trends in Microbiology. 19(11). 530–539. 157 indexed citations

11.

Lee, Im‐Soon, Young‐Jin Chun, Chul‐Ho Yun, et al.. (2011). Heterologous expression and characterization of the sterol 14α-demethylase CYP51F1 from Candida albicans. Archives of Biochemistry and Biophysics. 509(1). 9–15. 24 indexed citations

12.

Jensen, Kenneth, Jonathan B. Johnston, Paul R. Ortiz de Montellano, & Birger Lindberg Møller. (2011). Photosystem I from plants as a bacterial cytochrome P450 surrogate electron donor: terminal hydroxylation of branched hydrocarbon chains. Biotechnology Letters. 34(2). 239–245. 21 indexed citations

13.

Ouellet, Hugues, Shenheng Guan, Jonathan B. Johnston, et al.. (2010). Mycobacterium tuberculosis CYP125A1, a steroid C27 monooxygenase that detoxifies intracellularly generated cholest‐4‐en‐3‐one. Molecular Microbiology. 77(3). 730–742. 100 indexed citations

14.

Johnston, Jonathan B., Hugues Ouellet, Larissa M. Podust, & Paul R. Ortiz de Montellano. (2010). Structural control of cytochrome P450-catalyzed ω-hydroxylation. Archives of Biochemistry and Biophysics. 507(1). 86–94. 56 indexed citations

15.

Johnston, Jonathan B., Hugues Ouellet, & Paul R. Ortiz de Montellano. (2010). Functional Redundancy of Steroid C26-monooxygenase Activity in Mycobacterium tuberculosis Revealed by Biochemical and Genetic Analyses. Journal of Biological Chemistry. 285(47). 36352–36360. 79 indexed citations

16.

Doyle, Patricia S., Chiung-Kuang Chen, Jonathan B. Johnston, et al.. (2010). A Nonazole CYP51 Inhibitor Cures Chagas’ Disease in a Mouse Model of Acute Infection. Antimicrobial Agents and Chemotherapy. 54(6). 2480–2488. 53 indexed citations

17.

Ouellet, Hugues, Jonathan B. Johnston, & Paul R. Ortiz de Montellano. (2009). The Mycobacterium tuberculosis cytochrome P450 system. Archives of Biochemistry and Biophysics. 493(1). 82–95. 71 indexed citations

18.

Johnston, Jonathan B., P.M. Kells, Larissa M. Podust, & Paul R. Ortiz de Montellano. (2009). Biochemical and structural characterization of CYP124: A methyl-branched lipid ω-hydroxylase from Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences. 106(49). 20687–20692. 85 indexed citations

19.

Rothman, Steven C., Jonathan B. Johnston, Sungwon Lee, Joel R. Walker, & C. Dale Poulter. (2008). Type II Isopentenyl Diphosphate Isomerase: Irreversible Inactivation by Covalent Modification of Flavin. Journal of the American Chemical Society. 130(14). 4906–4913. 29 indexed citations

20.

Johnston, Jonathan B., Joel R. Walker, Steven C. Rothman, & C. Dale Poulter. (2007). Type-2 Isopentenyl Diphosphate Isomerase. Mechanistic Studies with Cyclopropyl and Epoxy Analogues. Journal of the American Chemical Society. 129(25). 7740–7741. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact